4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-20-131223
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Dec 01, 2020
Reporting period: Nov 30, 2020
Description: Insider transaction

Documents

0001104659-20-131223-index.htm

Complete submission

0001104659-20-131223.txt

directory listing

Filed by

Nabriva Therapeutics plc